Molecular mechanisms in C-Phycocyanin induced apoptosis in human chronic myeloid leukemia cell line-K562

Biochemical Pharmacology

Volumn 68, Issue 3, 2004, Pages 453-462

  Subhashini, Jagu ^a   Mahipal, Suraneni V K ^a   Reddy, Madhava C ^a   Reddy, Metukuri Mallikarjuna ^a   Rachamallu, Aparna ^a   Reddanna, Pallu ^a  

^a UNIVERSITY OF HYDERABAD   (India)

Author keywords

Apoptosis; Bcl 2; C PC; C Phycocyanin; chronic myeloid leukemia; CML; COX; cyclooxygenase; Cytochrome c; FACS; fluorescence activated cell sorter; K562 human chronic myeloid leukemia cell line; PARP

Indexed keywords

AGAROSE; ANTINEOPLASTIC AGENT; C PHYCOCYANIN; CYTOCHROME C; DNA FRAGMENT; GENOMIC DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHYCOCYANIN; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DEATH; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ELECTRON MICROSCOPY; ELECTROPHORESIS; ENZYME DEGRADATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MEMBRANE DAMAGE; MITOSIS INHIBITION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL DIVISION; CYTOCHROMES C; DNA FRAGMENTATION; HUMANS; IMMUNOBLOTTING; K562 CELLS; LEUKEMIA, MYELOID, CHRONIC; PHYCOCYANIN; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 3042739279     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.02.025     Document Type: Article

References (57)

1. Miranda M.S., Cintra R.G., Barros S.B., Mancini Filho J. Antioxidant activity of the micro alga Spirulina maxima. Braz. J. Med. Biol. Res. 31:1998;1075-1079
2. Chamorro G., Salazar M., Favila L., Bourges H. Pharmacology and toxicology of Spirulina alga. Rev. Invest. Clin. 48:1996;389-399
3. Ayehunie S., Belay A., Baba T.W., Ruprecht R.M. Inhibition of HIV-1 replication by an aqueous extract of Spirulina platensis (Arthrospira platensis). J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18:1998;7-12
4. Chen F., Zhang Q. Inhibitive effects of Spirulina on aberrant crypts in colon induced by dimethylhydrazine. Zhonghua Yu Fang Yi Xue Za Zhi. 29:1995;13-17
5. Schwartz J., Shklar G., Reid S., Trickler D. Prevention of experimental oral cancer by extracts of Spirulina-Dunaliella algae. Nutr. Cancer. 11:1988;127-134
6. Kim H.M., Lee E.H., Cho H.H., Moon Y.H. Inhibitory effect of mast cell-mediated immediate-type allergic reactions in rats by Spirulina. Biochem. Pharmacol. 55:1998;1071-1076
7. Qureshi M.A., Garlich J.D., Kidd M.T. Dietary Spirulina platensis enhances humoral and cell-mediated immune functions in chickens. Immunopharmacol. Immunotoxicol. 18:1996;465-476
8. Gonzalez de Rivera C., Miranda-Zamora R., Diaz-Zagoya J.C., Juarez-Oropeza M.A. Preventive effect of Spirulina maxima on the fatty liver induced by a fructose-rich diet in the rat, a preliminary report. Life Sci. 53:1993;57-61
9. Paredes-Carbajal M.C., Torres-Duran P.V., Diaz-Zagoya J.C., Mascher D., Juarez-Oropeza M.A. Effects of dietary Spirulina maxima on endothelium dependent vasomotor responses of rat aortic rings. Life Sci. 61:1997;211-219
10. Iwata K., Inayama T., Kato T. Effects of Spirulina platensis on plasma lipoprotein lipase activity in fructose-induced hyperlipidemic rats. J. Nutr. Sci. Vitaminol. (Tokyo). 36:1990;165-171
11. Vadiraja B.B., Madyastha K.M. C-PC: a potent peroxyl radical scavenger in vivo and in vitro. Biochem. Biophys. Res. Commun. 275:2000;20-25
12. Romay C., Ledon N., Gonzalez R. Phycocyanin extract reduces leukotriene B4 levels in arachidonic acid-induced mouse-ear inflammation test. J. Pharm. Pharmacol. 51:1999;641-642
13. Gonzalez R., Rodriguez S., Romay C., Gonzalez A., Armesto J., Remirez D., et al. Anti-inflammatory activity of Phycocyanin extract in acetic acid induced colitis in rats. Pharmacol. Res. 39:1999;1055-1059
14. Rimbau V., Camins A., Pubill D., Sureda F.X., Romay C., Gonzalez R., et al. C-PC protects cerebellar granule cells from low potassium/serum deprivation-induced apoptosis. Naunyn Schmiedebergs Arch. Pharmacol. 364:2000;96-104
15. Morcos N.C., Berns M., Henry W.L. Phycocyanin: laser activation, cytotoxic effects, and uptake in human atherosclerotic plaque. Lasers Surg. Med. 8:1988;10-17
16. Reddy M.C., Vadiraja B.B., Kiranmai G., Reddy M.N., Reddanna P., Madyastha K.M. Selective inhibition of cyclooxygenase-2 by C-Phycocyanin, a biliprotein from Spirulina platensis. Biochem. Biophys. Res. Commun. 277:2000;599-603
17. Reddy M.C., Subhashini J., Mahipal S.V.K., Vadiraja B.B., Srinivas Reddy P., Kiranmai G., et al. C-Phycocyanin, a selective cyclooxygenase-2 inhibitor, induces apoptosis in lipopolysaccharide-stimulated RAW 264.7 macrophages. Biochem. Biophys. Res. Commun. 304:2003;385-392
18. Pardhasaradhi B.V.V., Mubarak Ali A., Leela Kumari A., Reddanna P., Ashok K. Phycocyanin mediated apoptosis in AK-5 tumor cells involves downregulation of Bcl-2 and generation of ROS. Mol. Cancer Ther. 2:2003;1165-1170
19. Taketo M.M. Cyclooxygenase-2 inhibitors in tumorigenesis. J. Natl. Cancer Inst. 90:1998;1529-1536
20. Taketo M.M. Cyclooxygenase-2 inhibitors in tumorigenesis. J. Natl. Cancer Inst. 90:1998;1609-1620
21. Schreinemachers D.M., Everson R.B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology. 5:1994;138-146
22. Hara A., Yoshimi N., Niwa M., Ino N., Mori H. Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines. Jpn. Cancer Res. 88:1997;600-604
23. Sawaoka H., Kawano S., Tsuji S., Tsujii M., Gunawan E.S., Takei Y., et al. Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am. J. Physiol. 274:1998;G1061-G1067
24. Liu X.H., Yao S., Kirschenbaum A., Levine A.C. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res. 58:1998;4245-4249
25. Chan T.A. Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer: a chemoprevention. Lancet Oncol. 3:2002;166-174
26. Thun M.J., Namboodiri M.M., Calle E.E., Flanders W.D., Heath C.W. Jr. Aspirin use and risk of fatal cancer. Cancer Res. 53:1993;1322-1327
27. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63
28. Hermann M., Lorenz H.M., Voll R., Grunke M., Woith W., Kalden J.R. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res. 22:1994;5506-5507
29. Chandra J., Niemer I., Gilbreath J., Kliche K.O., Andreeff M., Freireich E.J., et al. Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytes. Blood. 92:1998;4220-4229
30. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254
31. Liu X., Kim C.N., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 86:1996;147-157
32. Martinou J.C., Desagher S., Antonsson B. Cytochrome c release from mitochondria: all or nothing. Nat. Cell Biol. 2:2000;E41-E43
33. Shah G.M., Shah R.G., Poirier G.G. Different cleavage pattern of poly(ADP-Ribose) ploymerase during necrosis and apoptosis in HL60 cells. Biochem. Biophys. Res. Commun. 229:1996;838-844
34. Sheng H., Shao J., Morrow J.D., Beauchamp R.D., DuBois R.N. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res. 58:1998;362-366
35. Noda H., Amano H., Arashima K., Hashimoto S., Nishizawa K. Studies on the antitumor activity of marine algae. Bull. Jpn. Soc. Sci. Fish. 55:1989;1254-1264
36. Riou D., Colliec-Jouaults S., pinczon du Sel D., Bosch S., Siavoshian S., Le Bert V., et al. Antitumor and antiproliferative effects of a fucan extracted from ascophyllum nodosum against a non-small-cell bronchopulmonary carcinoma line. Anticancer Res. 16:1996;1213-1218
37. Sadnori M., Hiroyoshi M., Kyoko N., Fuminori K. Effect of seaweed preparations on murine immunocytes. J. Appl. Phycol. 5:1993;629-637
38. Morcos N.C., Berns M., Henry W.L. Phycocyanin: laser activation, cytotoxic effect and uptake in human artherosclerotic plaque. Laser Surg. Med. 8:1988;10-17
39. Vadiraja B.B., Gaikwad N.W., Madyastha K.M. Hepatoprotective effect of C-phycocyanin: protection for carbon tetrachloride and R-(+)-pulegone-mediated hepatotoxicty in rats. Biochem. Biophys. Res. Commun. 249:1998;428-431
40. Romay C., Gonzalez R. Phycocyanin is an antioxidant protector of human erythrocytes against lysis by peroxyl radicals. J. Pharm. Pharmacol. 52:2000;367-368
41. Romay C., Ledon N., Gonzalez R. Further studies on anti-inflammatory activity of phycocyanin in some animal models of inflammation. Inflamm. Res. 47:1998;334-338
42. Yano H., Mizoguchi A., Fukuda K., Haramaki M., Ogasawara S., Momosaki S., et al. The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. Cancer Res. 54:1994;448-454
43. Tseng C.J., Wang Y.J., Liang Y.C., Jeng J.H., Lee W.S., Lin J.K., et al. Microtubule damaging agents induce apoptosis in HL 60 cells and G2/M cell cycle arrest in HT 29 cells. Toxicology. 175:2002;123-142
44. Shiff S.J., Qiao L., Tsai L.L., Rigas B. Sulindac sulfide, an aspirin-like compound inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. Clin. Invest. 96:1995;491-503
45. Bellosillo B., Pique M., Barragan M., Castano E., Villamor N., Colomer D., et al. Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood. 92:1998;1406-1414
46. Hanif R., Pittas A., Feng Y., Koutsos M.I., Qiao L., Staiano-Coico L., et al. Effects of non-steroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol. 52:1996;237-245
47. Hatefi Y. The mitochondrial electron transport and oxidative phosphorylation system. Annu. Rev. Biochem. 54:1985;1015-1069
48. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic proteasecascade. Cell. 91:1997;479-489
49. Li M., Wu X., Xu X.C. Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway in esophageal cancer cells. Int. J. Cancer. 93:2001;218-223
50. Nicholson W., Thornberry N.A. Caspases: killer proteases. Trends Biochem. Sci. 22:1997;299-306
51. Mashima T., Naito M., Noguchi K., Miller D.K., Nicholson D.W., Tsuruo T. Actin cleavage by CPP-32/apopain during the development of apoptosis. Oncogene. 14:1997;1007-1012
52. Martin S.J., O'Brien G.A., Nishioka W.K., McGahon A.J., Mahboubi A., Saido T.C., et al. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J. Biol. Chem. 270:1995;6425-6428
53. Lazebnik Y.A., Kaufmann S.H., Desnoyers S., Poirier G.G., Earnshaw W.C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 371:1994;346-347
54. Kothakota S., Azuma T., Reinhard C., Klippel A., Tang J., Chu K., et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science. 278:1997;294-298
55. 2+-dependent endonuclease activity by nicotinamide adenine dinucleotide and poly(adenosine diphosphate ribose) synthetase. Biochem. Biophys. Res. Commun. 59:1974;658-665
56. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 281:1998;1322-1326
57. Zamzami N., Marchetti P., Castedo M., Hirsch T., Susin S.A., Masse B., et al. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett. 384:1996;53-57